<<

CORRESPONDENCE LINK TO ORIGINAL ARTICLE LINK TO INITIAL CORRESPONDENCE

to determine what conditions in vivo favour piecemeal degranulation and what condi- cytolysis and release of tions promote cytolysis (with or without ‘net’ formation) and release of intact granules. cell-free granules There are several strong recent reviews cover- ing mechanisms of degranulation, including 10 Helene F. Rosenberg and Paul S. Foster those written by Neves and Weller , and Lacy and Moqbel11, for those seeking greater insight into this important and evolving field. We are grateful for an excellent oppor- The results of eosinophil cytolysis — Helene F. Rosenberg is in the tunity to expand on our recent Review specifically, the release of intact granules — Immunobiology Section, National Institute of (: changing perspectives in are not new findings. There have been many and Infectious Diseases, National Institutes of Health, health and disease. Nature Rev. Immunol. reports of free granules in tissues found in Bethesda, Maryland 20892, USA. 13, 9–22 (2013))1 that has been provided by conjunction with eosinophil-associated dis- Paul S. Foster is at the Priority Research Center the correspondence from Carl Persson and eases, including allergic rhinitis, bronchial for Asthma and Respiratory Diseases, Hunter Medical Research Institute and School of Lena Uller (Primary lysis of eosinophils asthma, atopic dermatitis, urticaria and Biomedical Sciences and Pharmacy, Faculty of Health, 7 as a major mode of activation of eosino- eosinophilic esophagitis . However, it was University of Newcastle, Newcastle, New South Wales, phils in human diseased tissues. Nature not clear what role these granules had, if any, 2300, Australia. Rev. Immunol. http://dx.doi.org/10.1038/ in promoting health or disease. This issue e-mails: [email protected]; 2 nri3341-c1 (2013)) . To recap: researchers was addressed by the recent work of Neves, [email protected] in the eosinophil field have defined three Moqbel, Weller and colleagues7, who made a 1. Rosenberg, H. F., Dyer, K. D. Foster, P. S. Eosinophils: main mechanisms of degranulation. The substantial step forward by showing us that changing perspectives in health and disease. first, , in which cytoplasmic granules could function in a cell-free state and Nature Rev. Immunol. 13, 9–22 (2013). 2. Persson, C. & Uller, L. Primary lysis of eosinophils as a granules fuse with the plasma could secrete immunomodulatory mediators. major mode of activation of eosinophils in human and release all of their contents into the Specifically, granules isolated by subcellular diseased tissues. Nature Rev. Immunol. http://dx.doi. org/10.1038/nri3341-c1 (2013). extracellular space en masse, is not typically fractionation express the interferon‑γ (IFNγ) 3. Dvorak, A. M. et al. Piecemeal degranulation of observed in vivo. A second type of degranu- receptor and CC‑ receptor 3 specific granules and distribution of Charcot-Leyden crystal protein. Am. J. Pathol. 138, 69–82 (1991). lation, piecemeal degranulation, is a process (CCR3) on their and release the 4. Melo, R. C. & Weller, P. F. Piecemeal degranulation in that was first defined by the electron micro- cationic ribonuclease eosinophil cationic human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histol. scopic observations of Dvorak and col- protein (ECP) in a dose-dependent fashion in Histopathol. 25, 1341–1354 (2010). leagues3, who noted that, similarly to what response to either IFNγ- or CC‑chemokine 5. Melo, R. C., Perez, S. A., Spencer, L. A., Dvorak, A. M. & Weller, P. F. Intragranular vesiculotubular compartments had been observed for , eosinophil ligand 11 (CCL11; also known as are involved in piecemeal degranulation by activated granules do not empty as completely or as eotaxin 1)-mediated stimulation via a p38 human eosinophils. Traffic 6, 866–879 (2005). 6. Spencer, L. A. et al. Cytokine receptor-mkediated explosively as would be anticipated if exo- mitogen-activated protein kinase (MAPK)- trafficking of preformed IL‑4 in eosinophils identifies were taking place4. As discussed in dependent signalling pathway7. Other recep- an innate immune mechanism of cytokine secretion. 1 Proc. Natl Acad. Sci. USA 28, 3333–3338 (2006). detail in the original Review , recent studies tors that have been identified on cell-free 7. Neves, J. S. et al. Eosinophil granules function by Spencer, Melo, Weller and colleagues5,6 eosinophil granules include cysteinyl leuko­ extracellularly as receptor-mediated secretory organelles. Proc. Natl Acad. Sci. USA 105, have identified tubulovesicular subcellular triene receptor 1 (CYSLTR1), CYSLTR2 and 18478–18483 (2008). structures and have elucidated receptor– P2Y purinoceptor 12 (P2RY12)8. Likewise, 8. Neves, J. S., Radke, A. L. & Weller, P. F. Cysteinyl acting via membrane-expressed chaperone systems that are the among the as noted by Uller and Persson, Ueki and col- receptors elicit secretion from within cell-free human important features underlying piecemeal leagues9 have reported (since the publication eosinophil granules. J. Allergy Clin. Immunol. 125, 477–482 (2010). degranulation. of our Review) that the release of mitochon- 9. Ueki, S. et al. Eosinophil extracellular DNA trap cell However, a third mechanism, which was drial DNA ‘nets’, which is another form of death mediates lytic release of free secretion- competent eosinophl granules in humans. Blood 121, covered more briefly, is cytolysis. Cytolylsis cytolysis, is also accompanied by the release of 2074–2083 (2013). is classified as a form of degranulation intact granules. 10. Neves, J. S. & Weller, P. F. Functional extracellular eosinophil granules: novel implications in eosinophil because, as was recently shown, it is not Among the important questions that immunobiology. Curr. Opin. Immunol. 21, 694–699 purely ‘death’ but a way for eosinophils to remain to be explored, it is not clear whether (2009). 11. Lacy, P. & Moqbel, R. in Eosinophils in Health and live on functionally and to have an impor- the mechanisms of protein trafficking found in Disease Ch. 7.6 (eds Lee, J. J. & Rosenberg, H. F.) tant and ongoing immunomodulatory intact cells also take place in granules, and/or 206–218 (Elsevier, 2012). impact on eosinophil-enriched organs and if individual proteins can be selectively mobi- Competing interests statement tissues. lized. Equally interesting, it will be important The authors declare no competing financial interests.

NATURE REVIEWS | IMMUNOLOGY www.nature.com/reviews/immunol

© 2013 Macmillan Publishers Limited. All rights reserved